This formulation may not include additional additives but comes with the regulatory assurance of 503b compliance
4 Discussion At present, the therapeutic options available for pediatric patients with diabetes are somewhat limited, only insulin, metformin, daily liraglutide and once-weekly exenatide extended release are applied in clinical practice
Risk of bias was assessed using the Cochrane Risk of Bias 2 (RoB2) tool for RCTs, the Newcastle-Ottawa Scale (NOS) for cohort studies, and Joanna Briggs Institute (JBI) checklists for case reports, case series, and pharmacovigilance studies
With continuing developments in the field of GLP-1 RA therapy, it is important for physicians to understand the benefits and practical use of GLP-1 RAs, as well as the clinical evidence, in order to achieve positive patient outcomes
Within a substrate-aware framework, clinical surveillance may therefore include periodic assessment of (i) lean mass trajectory, (ii) micronutrient statusparticularly nutrients supporting enzymatic throughput and redox cyclingand (iii) fat-soluble vitamin indices as indirect indicators of bile-dependent absorption integrity